14.7

Medical Imaging and Diagnostics

Chapter contents: Chapter 14: Nuclear and Particle Physics

Most medical and related applications of nuclear physics are driven, at their core, by the difference between a radioactive substance and a non-radioactive substance. One of the first such methods is the precision measurement and detection method known as radioimmunoassay (RIA). Developed by Rosalyn Sussman Yalow and Solomon Berson in the late 1950s, RIA relies on the principle of competitive binding. For the particular substance being measured, a radioactively labeled sample is prepared and mixed with the unlabeled substance being measured. A known quantity of antibodies is then introduced. By measuring the radioactivity in the bound or unbound fraction after the reaction, technicians can detect and measure the precise amount of the target substance. Radioimmunoassay is essential in cancer screening, hepatitis diagnosis, narcotics investigation, and other analyses.
A host of medical imaging techniques employ nuclear radiation. What makes nuclear radiation so useful? First, γ radiation can easily penetrate tissue; hence, it is a useful probe to monitor conditions inside the body. Second, nuclear radiation depends on the nuclide and not on the chemical compound it is in, so that a radioactive nuclide can be put into a compound designed for specific purposes. The compound is said to be tagged. A tagged compound used for medical purposes is called a radiopharmaceutical. Radiation detectors external to the body can determine the location and concentration of a radiopharmaceutical to yield medically useful information. For example, certain drugs are concentrated in inflamed regions of the body, and this information can aid diagnosis and treatment as seen in Figure 14.7.1. Another application utilizes a radiopharmaceutical which the body sends to bone cells, particularly those that are most active, to detect cancerous tumors or healing points. Images can then be produced of such bone scans. Radioisotopes are also used to determine the functioning of body organs, such as blood flow, heart muscle activity, and iodine uptake in the thyroid gland.
A brain scan. Different regions of the brain are shown in different colors.
Figure 14.7.1. A radiopharmaceutical is used to produce this brain image of a patient with Alzheimer’s disease. Certain features are computer enhanced. (credit: National Institutes of Health)

Medical Application

Table 14.7.1 lists selected medical diagnostic uses of radiopharmaceuticals, including named preparations and adult activity ranges from their product labels. Many organs can be imaged with a variety of nuclear isotopes replacing a stable element by a radioactive isotope. One common diagnostic employs radioactive iodine to image the thyroid, since iodine is concentrated in that organ. Thyroid tissue that concentrates more radioactive iodine emits more radiation. A gamma camera detects this radiation to form an image showing how the iodine is distributed within the thyroid. Note that there is more than one isotope that can be used for several types of scans. Another common nuclear diagnostic is the thallium scan for the cardiovascular system, particularly used to evaluate blockages in the coronary arteries and examine heart activity. The salt TlCl can be used, because thallium is taken up by viable heart muscle cells in a manner similar to potassium. Gallium-67 accumulates where there is rapid cell growth, such as in tumors and sites of infection. Hence, it is useful in cancer imaging. Usually, the patient receives the injection one day and has a whole body scan 3 or 4 days later because it can take several days for the gallium to build up.
Table 14.7.1. Examples of Diagnostic Radiopharmaceuticals [Note: Examples of adult administered activities from the named product labels, not a comprehensive list of imaging protocols. For I-123, the label places uptake-only studies at the lower end and thyroid imaging at the higher end of the range. Activity measures decays per second, not absorbed or effective dose; 1 mCi = 37 MBq. Sources (checked September 2026): DailyMed: DRAXIMAGE MDP-25 (technetium Tc 99m medronate), Dosage and Administration; DailyMed: DRAXIMAGE MAA, section 2.3; GE HealthCare: CERETEC prescribing information, section 2.2; DailyMed: Sodium Iodide I 123, Dosage and Administration; DailyMed: Fludeoxyglucose F 18, section 2.1.]
Diagnostic useRadiopharmaceuticalAdult activity (MBq)Adult activity (mCi)
Bone imagingTc-99m medronate (MDP)370–74010–20
Lung perfusionTc-99m aggregated albumin (MAA)37–1481–4
Brain perfusionTc-99m exametazime (CERETEC)555–111015–30
Thyroid uptake and imagingSodium iodide I-1233.7–14.80.1–0.4
PET imaging of glucose metabolismFludeoxyglucose F-18 (FDG)185–3705–10
Note that Table 14.7.1 lists several diagnostic uses for Tc99m, where “m” stands for a metastable state of the technetium nucleus. Perhaps 80 percent of all radiopharmaceutical procedures employ Tc99m because of its many advantages. One is that the decay of its metastable state produces a single, easily identified 0.141-MeV γ ray. Additionally, the radiation dose to the patient is limited by the short 6.0-h half-life of Tc99m. On site, technetium-99m is commonly obtained from a generator containing molybdenum-99, which decays to technetium-99m. Technetium-99m can be attached to many compounds to allow the imaging of the skeleton, heart, lungs, kidneys, etc.
Figure 14.7.2 shows one of the simpler methods of imaging the concentration of nuclear activity, employing a device called an Anger camera or gamma camera. A piece of lead with holes bored through it collimates γ rays emerging from the patient, allowing detectors to receive γ rays from specific directions only. The computer analysis of detector signals produces an image. One of the disadvantages of this detection method is that there is no depth information (i.e., it provides a two-dimensional view of the tumor as opposed to a three-dimensional view), because radiation from any location under that detector produces a signal.
The image shows the head of a man scanned by an Anger camera. The camera consists of a lead collimator and array of detectors. Gamma rays emerging from the man’s head pass through the lead collimator and produce light flashes in the scintillators. The photomultiplier tubes convert the light output to electrical signals for computer image generation.
Figure 14.7.2. An Anger or gamma camera consists of a lead collimator and an array of detectors. Gamma rays produce light flashes in the scintillators. The light output is converted to an electrical signal by the photomultipliers. A computer constructs an image from the detector output.
Imaging techniques much like those in x-ray computed tomography (CT) scans use nuclear activity in patients to form three-dimensional images. Figure 14.7.3 shows a patient in a circular array of detectors that may be stationary or rotated, with detector output used by a computer to construct a detailed image. This technique is called single-photon-emission computed tomography (SPECT) or sometimes simply SPET. The spatial resolution of this technique is poor, about 1 cm, but the contrast (i.e. the difference in visual properties that makes an object distinguishable from other objects and the background) is good.
A man lying down, going through a cylindrical scanning machine.
Figure 14.7.3. SPECT uses a geometry similar to a CT scanner to form an image of the concentration of a radiopharmaceutical compound. (credit: Woldo, Wikimedia Commons)
Images produced by β+ emitters have become important in recent years. When the emitted positron (β+) encounters an electron, mutual annihilation occurs, producing two γ rays. These γ rays have identical 0.511-MeV energies (the energy comes from the conversion of the electron’s and positron’s rest energy into photon energy) and they move directly away from one another, allowing detectors to determine their point of origin accurately, as shown in Figure 14.7.4. The system is called positron emission tomography (PET). It requires detectors on opposite sides to simultaneously (i.e., at the same time) detect photons of 0.511-MeV energy and utilizes computer imaging techniques similar to those in SPECT and CT scans. Examples of β+-emitting isotopes used in PET are C11, N13, O15, and F18. This list includes C, N, and O, and so they have the advantage of being able to function as tags for natural body compounds. Its resolution of 0.5 cm is better than that of SPECT; the accuracy and sensitivity of PET scans make them useful for examining the brain’s anatomy and function. The brain’s use of oxygen and water can be monitored with O15. PET is used extensively for diagnosing brain disorders. It can note decreased metabolism in certain regions prior to a confirmation of Alzheimer’s disease. PET can locate regions in the brain that become active when a person carries out specific activities, such as speaking, closing their eyes, and so on.
The figure shows a patient undergoing a scan in a cylindrical device. The P E T system uses two gamma ray photons produced by positron electron annihilation. These gamma rays are emitted in opposite directions.
Figure 14.7.4. A PET system takes advantage of the two identical γ-ray photons produced by positron-electron annihilation. These γ rays are emitted in opposite directions, so that the line along which each pair is emitted is determined. Various events detected by several pairs of detectors are then analyzed by the computer to form an accurate image.
Continue to this item in the chapter review.Continue to this item in the chapter review.Continue to this item in the chapter review.Continue to this item in the chapter review.Continue to this item in the chapter review.Continue to this item in the chapter review.Continue to this item in the chapter review.Continue to this item in the chapter review.Continue to this item in the chapter review.Continue to this item in the chapter review.Continue to this item in the chapter review.Continue to this item in the chapter review.Continue to this item in the chapter review.Continue to this item in the chapter review.Continue to this item in the chapter review.Continue to this item in the chapter review.Continue to this item in the chapter review.Continue to this item in the chapter review.Continue to this item in the chapter review.Continue to this item in the chapter review.Continue to this item in the chapter review.Continue to this item in the chapter review.Continue to this item in the chapter review.Continue to this item in the chapter review.Continue to this item in the chapter review.Continue to this item in the chapter review.Continue to this item in the chapter review.Continue to this item in the chapter review.Continue to this item in the chapter review.Continue to this item in the chapter review.Continue to this item in the chapter review.
Continue to this item in the chapter review.Continue to this item in the chapter review.Continue to this item in the chapter review.Continue to this item in the chapter review.Continue to this item in the chapter review.Continue to this item in the chapter review.Continue to this item in the chapter review.Continue to this item in the chapter review.Continue to this item in the chapter review.Continue to this item in the chapter review.Continue to this item in the chapter review.Continue to this item in the chapter review.